Ondansetron, dexamethasone and an NK1 antagonist block radiation sickness in mice.
Radiation sickness is frequently observed in total body irradiation (TBI). We have reported that the kaolin ingestion behavior "pica" may be analogous to nausea and vomiting in mice. We evaluated the effects of anti-emetics on the prevention of radiation-induced pica in mice. After the intraperitoneal injection of ondansetron (OND: 2 mg/kg), dexamethasone (DEX: 2 mg/kg) or CP-99,994 (CP: 15 mg/kg), mice received 9 Gy of TBI, and then kaolin consumption was measured after 24 h. Radiation-induced pica was slightly inhibited by pretreatment with a single administration of OND or DEX, but not by CP (control: 0.69+/-0.19 g, OND: 0.33+/-0.06 g, DEX: 0.39+/-0.07 g, CP: 0.66+/-0.09 g); it was significantly inhibited by the combination treatment of OND and DEX (control: 0.55+/-0.09 g, OND+DEX: 0.30+/-0.06 g, OND+CP: 0.70+/-0.04 g, DEX+CP: 0.58+/-0.02 g). The combination of the three drugs completely abolished the behavior (control: 0.67+/-0.08 g, OND+DEX+CP: 0.10+/-0.05 g). These results suggest that radiation-induced pica in mice may be useful to evaluate drugs for treatment of radiation sickness and that the combination therapy of a serotonin 5-HT3 receptor antagonist and a glucocorticosteroid with a neurokinin NK1 receptor antagonist is effective in reducing the symptom.
Yamamoto
Kouichi
K
Department of Medical Physics and Engineering, Graduate School of Allied Health Sciences, Faculty of Medicine, Osaka University, Yamadaoka 1-7, Suita, Osaka 565-0871, Japan. kouichi@sahs.med.osaka-u.ac.jp
Nohara
Kyoko
K
Furuya
Tomohisa
T
Yamatodani
Atsushi
A
D000818:Animals; D000932:Antiemetics / Q000008:administration & dosage / Q000494:pharmacology; D003907:Dexamethasone / Q000008:administration & dosage / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D064729:Neurokinin-1 Receptor Antagonists; D017294:Ondansetron / Q000008:administration & dosage / Q000494:pharmacology*; D010842:Pica / Q000139:chemically induced / Q000517:prevention & control; D010880:Piperidines / Q000008:administration & dosage / Q000494:pharmacology*; D011832:Radiation Injuries / Q000517:prevention & control*; D012702:Serotonin Antagonists / Q000008:administration & dosage / Q000494:pharmacology*
D000932:Antiemetics; D064729:Neurokinin-1 Receptor Antagonists; D010880:Piperidines; D012702:Serotonin Antagonists; C080755:3-(2-methoxybenzylamino)-2-phenylpiperidine; D017294:Ondansetron; D003907:Dexamethasone